Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Crisaborole in Mild to Moderate Atopic Dermatitis
NCT03539601Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Apr 2018
- Primary completion
- Dec 2020
- Countries
- 7
01
Overview
A Phase 4 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Pfizer. Started Apr 2018; status: terminated.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03539601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03539601.